Akinetic Crisis in Parkinson’s Disease Following the Withdrawal of Continuous Subcutaneous Foslevodopa-Foscarbidopa Infusion: A Case Report
Akinetic crisis (AC) in Parkinson's disease (PD) is a life-threatening complication precipitated by abrupt changes or the impaired absorption of dopaminergic medication. We report a case of AC precipitated by an unintended suspension of continuous subcutaneous foslevodopa-foscarbidopa infusion (CSFLI) in a patient with advanced PD in a perioperative setting. Our observations highlight that despite its reputation as a reliable device-aided therapy (DAT), CSFLI remains vulnerable to abrupt interruptions and it may entail an under-recognized risk of AC. This case underscores the need for alternative dopaminergic routes, careful perioperative planning, and multidisciplinary collaboration in managing patients with advanced PD undergoing DAT.
Authors
- Hideo Kihara
- Yugaku Daté
- 笠井陽介
- Kiyokazu Kawabe
- Koki Iritani
- Akihiro Warabi
- Kanon Kobayashi
- Tomoki Kamiya
Publication Details
- Journal
- Internal Medicine
- Published
- 2026-11-19
- DOI
- https://doi.org/10.2169/internalmedicine.7414-26
- Primary Topic
- Parkinson's Disease Mechanisms and Treatments
- Type
- article
- Field-Weighted Citation Impact
- 0.00